相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma
Alfredo D. Voloschin et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors
Sabine Wagner et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: A North American brain tumor consortium study
Monica E. Loghin et al.
CLINICAL CANCER RESEARCH (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography:: A pilot study
Wei Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non-small-cell lung cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemoradiotherapy in malignant glioma: Standard of care and future directions
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors
Chris Folkins et al.
CANCER RESEARCH (2007)
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors
Lynn G. Feun et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer
Jeffrey A. Allen et al.
ARCHIVES OF NEUROLOGY (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Prospective trial on topotecan salvage therapy in primary CNS lymphoma
L. Fischer et al.
ANNALS OF ONCOLOGY (2006)
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
MD Prados et al.
NEURO-ONCOLOGY (2006)
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan
C Gomez-Manzano et al.
CLINICAL CANCER RESEARCH (2006)
A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines
E Morandi et al.
CANCER LETTERS (2006)
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma
DA Reardon et al.
CANCER (2005)
Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models
MH Woo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
DA Reardon et al.
CANCER (2005)
Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases
M Kocher et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2005)
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma
DA Reardon et al.
NEURO-ONCOLOGY (2004)
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma
JA Quinn et al.
NEURO-ONCOLOGY (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma
ML Gruber et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy:: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
AA Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
MD Prados et al.
NEURO-ONCOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: Final report of NABTT 97-11
TT Batchelor et al.
NEURO-ONCOLOGY (2004)
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma
PB Storm et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Irinotecan in the treatment of glioma patients - Current and future studies of the North Central Cancer Treatment Group
JC Buckner et al.
CANCER (2003)
Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
A Salmaggi et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen
TF Cloughesy et al.
CANCER (2003)
Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma
TC Chen et al.
CANCER (2003)
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas
KD Weaver et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group 9513
B Fisher et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme
MC Chamberlain
JOURNAL OF NEURO-ONCOLOGY (2002)
Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft
DF Stefanik et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants
V Pavillard et al.
BRITISH JOURNAL OF CANCER (2001)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
